Get started
Author

Yuki Ikebuchi

Observed name: Ikebuchi Y
OpenAlex ID: A5066684522
Decreased extra-renal urate excretion is a common cause of hyperuricemia
2012 · Kimiyoshi Ichida, Hirotaka Matsuo, et al. · Nature Communications · 705
PDF
Coupling of bone resorption and formation by RANKL reverse signalling
2018 · Yuki Ikebuchi, Shigeki Aoki, et al. · Nature · 557
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
2009 · Hirotaka Matsuo, Tappei Takada, et al. · Science Translational Medicine · 439
RANKL subcellular trafficking and regulatory mechanisms in osteocytes
2013 · Masashi Honma, Yuki Ikebuchi, et al. · Journal of Bone and Mineral Research · 98
PDF
ABCG2 is a High-Capacity Urate Transporter and its Genetic Impairment Increases Serum Uric Acid Levels in Humans
2011 · Akiyoshi Nakayama, Hirotaka Matsuo, et al. · Nucleosides Nucleotides & Nucleic Acids · 93
Multiple common and rare variants of ABCG2 cause gout
2017 · Toshihide Higashino, Tappei Takada, et al. · RMD Open · 74
PDF
Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors
2014 · Masashi Honma, Yuki Ikebuchi, et al. · Current Osteoporosis Reports · 72
RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target
2020 · Masashi Honma, Yuki Ikebuchi, et al. · Pharmacology & Therapeutics · 55
Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport
2015 · Naoki Ito, Kousei Ito, et al. · Pharmaceutical Research · 37
Receptor for activated C‐kinase 1 regulates the cellular localization and function of ABCB4
2009 · Yuki Ikebuchi, Tappei Takada, et al. · Hepatology Research · 35
Organic Cation Transporter/Solute Carrier Family 22a is Involved in Drug Transfer into Milk in Mice
2014 · Naoki Ito, Kousei Ito, et al. · Journal of Pharmaceutical Sciences · 30
The induction of RANKL molecule clustering could stimulate early osteoblast differentiation
2018 · Eri Sone, Daisuke Noshiro, et al. · Biochemical and Biophysical Research Communications · 24
Mechanisms of RANKL delivery to the osteoclast precursor cell surface
2020 · Masashi Honma, Yuki Ikebuchi, et al. · Journal of Bone and Mineral Metabolism · 23
Posttranslational regulation of Abcc2 expression by SUMOylation system
2008 · Satoko Minami, Kousei Ito, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 20
Establishment of optimized in vitro assay methods for evaluating osteocyte functions
2013 · Masashi Honma, Yuki Ikebuchi, et al. · Journal of Bone and Mineral Metabolism · 18
Coupling of bone resorption and formation by RANKL reverse signalling
2019 · Ikebuchi Y, Aoki S, et al. · Yearbook of pediatric endocrinology · 14
Ursodeoxycholic acid stimulates the formation of the bile canalicular network
2012 · Yuki Ikebuchi, Hidetoshi Shimizu, et al. · Biochemical Pharmacology · 12
Receptor for Activated C-Kinase 1 Regulates the Cell Surface Expression and Function of ATP Binding Cassette G2
2010 · Yuki Ikebuchi, Kousei Ito, et al. · Drug Metabolism and Disposition · 8
RANKL subcellular trafficking in osteocytes
2013 · Masashi Honma, Yuki Ikebuchi, et al. · Bone Abstracts · 1
PDF
Elucidation of Bidirectional RANK–RANKL Signaling and Its Therapeutic Implications for Osteoporosis
2026 · Yuki Ikebuchi · YAKUGAKU ZASSHI
PDF
Comprehensive analysis on Wnt signaling pathway to develop a novel signal modifier
2024 · Yuki Ikebuchi · Impact
Possibility of RANKL as a pharmacological target
2022 · Honma Masashi, Keisuke Nakamura, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Works count: 22
Citation count: 2,315
H-index: 15
I10-index: 17
Year
Topic
Type